Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating Clinical Genome Sequence Analysis by Watson for Genomics.
Itahashi K, Kondo S, Kubo T, Fujiwara Y, Kato M, Ichikawa H, Koyama T, Tokumasu R, Xu J, Huettner CS, Michelini VV, Parida L, Kohno T, Yamamoto N. Itahashi K, et al. Among authors: koyama t. Front Med (Lausanne). 2018 Nov 9;5:305. doi: 10.3389/fmed.2018.00305. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30474028 Free PMC article.
Variant analysis of SARS-CoV-2 genomes.
Koyama T, Platt D, Parida L. Koyama T, et al. Bull World Health Organ. 2020 Jul 1;98(7):495-504. doi: 10.2471/BLT.20.253591. Epub 2020 Jun 2. Bull World Health Organ. 2020. PMID: 32742035 Free PMC article.
Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma.
Wrzeszczynski KO, Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Vacic V, Norel R, Bilal E, Bergmann EA, Moore Vogel JL, Bruce JN, Lassman AB, Canoll P, Grommes C, Harvey S, Parida L, Michelini VV, Zody MC, Jobanputra V, Royyuru AK, Darnell RB. Wrzeszczynski KO, et al. Among authors: koyama t. Neurol Genet. 2017 Jul 11;3(4):e164. doi: 10.1212/NXG.0000000000000164. eCollection 2017 Aug. Neurol Genet. 2017. PMID: 28740869 Free PMC article.
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.
Koyama T, Kiyota N, Boku S, Imamura Y, Shibata N, Satake H, Tanaka K, Hayashi H, Onoe T, Asada Y, Yamazaki T, Nose T, Ohata S, Nagatani Y, Kimbara S, Funakoshi Y, Teshima M, Shinomiya H, Minami H. Koyama T, et al. ESMO Open. 2024 Jun 3;9(6):103476. doi: 10.1016/j.esmoop.2024.103476. Online ahead of print. ESMO Open. 2024. PMID: 38833968 Free article.
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors.
Yamamoto N, Kuboki Y, Harano K, Koyama T, Kondo S, Hagiwara A, Suzuki N, Fujikawa E, Toyoizumi K, Mukai M, Doi T. Yamamoto N, et al. Among authors: koyama t. Invest New Drugs. 2024 Jun 4. doi: 10.1007/s10637-024-01433-3. Online ahead of print. Invest New Drugs. 2024. PMID: 38833067
3,126 results